« Back
Home /
FRAT1 Antibody - C-terminal region

FRAT1 Antibody - C-terminal region

Item no.	OAGA03593
Manufacturer	AVIVA Systems Biology
Amount	100 ul
Category	Oncology Neuroscience Neural Signaling Antibodies Immunohistochemistry Western Blot ELISA Immunofluorescence Immunocytochemistry Primary Antibodies By Organ Lymphatic System Cancer Immunochemistry
Type	Antibody Polyclonal
Format	Liquid
Applications	WB, IF, IHC, ICC
Specific against	Human (Homo sapiens), Mouse (Murine, Mus musculus)
Host	Rabbit
Isotype	IgG
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	Frequently rearranged in advanced T-cell lymphomas; FLJ97193;proto-oncogene FRAT1; FRAT-1
Shipping Condition	Cool pack
Available
Manufacturer - Type	Polyclonal Antibody
Manufacturer - Applications	ICC, IF, IHC-FFPE, WB
Manufacturer - Category	Root Catalog/Products/Polyclonal Antibodies, Root Catalog/Products/Primary Antibodies
Shipping Temperature	Wet Ice
Molecular Weight	29 kDa
Manufacturer - Application Additional Information	ICC: 1:100-1:1000 IF: 1:100-1:1000 IHC-FFPE: 1:100-1:1000 WB: 1:500-1:3000 Optimal dilutions should be determined by the end user.
Gene symbol	FRAT1
Gene Fullname	FRAT1, WNT signaling pathway regulator
Product format	Liquid. 0.1M Tris, 0.1M Glycine, 10% Glycerol (pH 7). 0.01% Thimerosal was added as a preservative.
Reconstitution and storage	Keep as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4C. For long-term storage, aliquot and store at -20C or below. Avoid multiple freeze/thaw cycles.
Description of target	The protein encoded by this gene belongs to the GSK-3-binding protein family. The protein inhibits GSK-3-mediated phosphorylation of beta-catenin and positively regulates the Wnt signaling pathway. It may function in tumor progression and in lymphomagenesis.
Nucleotide accession_num	NM_005479.3
Protein accession_num	NP_005470.2
Protein name	proto-oncogene FRAT1
Clonality	Polyclonal
Purification	Purified by antigen-affinity chromatography.
Immunogen	Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human FRAT1. The exact sequence is proprietary.
Concentration	1 mg/ml

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

OAGA03593-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 100 ul

available

Delivery expected until 1/29/2026

Express Delivery: Save 9 days

Compare

Add to wishlist

Get an offer